Full Length Research Paper
References
|
Brossier F (2011). Mechanisms of action and resistance to INH, a first-line antituberculous drug. J. Anti. infect. 10 (003). |
|
|
Chevalier B, Margery J, Sane M, Camara P, Lefebvre N, Gueye M, Thiam M, Perrier-Gros-Claude JD, Simon F, Fabre M, Soler C, Herve V, Mbaye PS, Debonne JM (2010). Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003). Rev. Pneumol. Clin. 66(4):266-271. |
|
|
Diop SA, Fortes Déguénonvo L, Manga NM, Dia NM, Ka D, Hounsou AS, Ndour CT, Soumaré M, Seydi M (2014). Epidemiological, clinical and evolutionary aspects of tuberculosis retreatment patients. RMIM. 3:9-13. |
|
|
FIND (2015). Line probe assay (1st line drugs). |
|
|
Kouassi B, Horo K, N'douba KA, Koffi N, Ngom A, Aka-Danguy E, Dosso M (2004). Epidemiological, clinical and biological profile of pulmonary tuberculosis in situation of failure or relapse in Abidjan. Bull.Soc. Pathol. Exot. 97(5):336-337. |
|
|
Kurbatova EV, Cavanaugh JS, Shah NS, Wright A, Kim H, Metchock B, Van Deun A, Barrera L, Boulahbal F, Richter E, Martin-Casabona N (2012). Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs. Int. J. Tuberc. Lung Dis. 16 (3):355-357. |
|
|
Mbatchou NBH, Diatta A, Touré NO, Dia Kane Y, Ba Diop S, Ndiaye EH, Niang A, Sah Belinga A, Agodokpessi G, Ngakoutou R, Thiam K, Hane AA (2008). Clinical, biological and radiological spectrum of newly diagnosed pulmonary tuberculosis. Rev. Mal. Respir. 25:22-26. |
|
|
Minime-Lingoupou F, Pierre-Audigier C, Kassa-Kélémbho E, Barilone N, Zandanga G, Rauzier J, Cadet-Daniel V, Le Faou A, Gicquel B (2010). Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic. Int.J.Tuberc. Lung. Dis.14(6):782-785. |
|
|
Prasad R, Gupta N, Singh M (2014). Multidrug-resistant tuberculosis: trends and control. Indian. J. Chest. Dis. Allied. Sci. 56:237-246. |
|
|
National Antituberculosis Program (PNT), Senegal. Annual Report, 2013. |
|
|
Rapid implementation of Xpert MTB/RIF (2011). WHO Report, Geneva. WHO/HTM/TB/ 2011.2. |
|
|
Sangaré L, Diandé S, Badoum G, Dingtoumda B, Traoré AS (2010). Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso. Int. J. Tuberc. Lung. Dis. 14(11):1424-1429. |
|
|
WHO (2015). WHO policy statement: molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
